Morgan Stanley Capital I Trust 2016-UBS11 Annual Report - How They Did This Year

I’m here to help you understand what’s happening with Morgan Stanley Capital I Trust 2016-UBS11. This isn't a typical company like Apple; it’s a Commercial Mortgage-Backed Security (CMBS) trust. Think of it as a "bucket" holding a collection of commercial property loans. You own "slices" of this bucket and earn money from the interest and principal payments those properties generate.

Here is the latest update on how things are moving:

1. What does this trust do and how did it perform?

The trust manages commercial real estate loans originated in 2016. The big news for 2025 is that the "Sixty Soho" mortgage, worth about $85 million, was fully repaid in December. This is a positive step. It removes that property from the trust, shrinks the "bucket," and returns the remaining principal to investors. This also lowers your exposure to the New York City hotel and retail market.

2. Financial performance

The Sixty Soho repayment confirms the trust is healthy. When a loan is repaid, the owner has successfully refinanced or sold the building, and the trust receives its full principal back plus interest. The trust continues to collect payments from its remaining assets. The largest is the Vertex Pharmaceuticals headquarters in Boston, with a balance of about $175 million. This high-quality office property provides steady, long-term cash for the trust’s senior investors.

3. Major wins and changes: The "Servicing" Shake-up

You may notice administrative changes in the paperwork. "Servicers" act like property managers for these loans; they handle billing, collections, and oversight.

• The Big Transition: On March 1, 2025, Trimont LLC took over loan servicing from Wells Fargo. Trimont now manages the loans, collects monthly payments, and monitors property reports.
• Special Servicer: Greystone Servicing Company LLC remains the "Special Servicer." They step in if a loan defaults or needs a workout, such as a modification or foreclosure.
• Consistency: All new parties passed their compliance audits, ensuring the "plumbing" of the trust—how cash flows to you—is working exactly as planned.

4. Key risks

The main risk here is "concentration risk." The trust holds a small number of large loans, with the top 10 loans making up over 65% of the remaining balance. If one major tenant or owner struggles, it significantly affects your investment. For example, the Vertex Pharmaceuticals loan is a major part of the remaining cash flow. If that tenant fails or doesn't renew their lease, it could impact the trust’s ability to pay interest to subordinate investors.

5. Future outlook

With the Sixty Soho loan gone, the trust is more streamlined, and the total pool balance dropped by about 12% this year. The transition to new servicers is complete and verified. The trust is now focused on its remaining core assets, which are mostly stable office and industrial properties. These sectors have historically been more resilient than the hospitality market.

Investor Takeaway: When reviewing your position, keep an eye on the concentration of the top remaining loans. Because the trust is now smaller and more focused, the performance of the largest assets—like the Vertex Pharmaceuticals headquarters—will have a greater impact on your returns than ever before.